121 related articles for article (PubMed ID: 20846610)
1. N-acetylcysteine somewhere between Scylla and Charybdis.
Sochman J
J Am Coll Cardiol; 2010 Sep; 56(13):1067; author reply 1067-8. PubMed ID: 20846610
[No Abstract] [Full Text] [Related]
2. Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) Trial.
Thiele H; Hildebrand L; Schirdewahn C; Eitel I; Adams V; Fuernau G; Erbs S; Linke A; Diederich KW; Nowak M; Desch S; Gutberlet M; Schuler G
J Am Coll Cardiol; 2010 May; 55(20):2201-9. PubMed ID: 20466200
[TBL] [Abstract][Full Text] [Related]
3. N-acetylcysteine and contrast-induced nephropathy.
Balderramo DC
N Engl J Med; 2006 Oct; 355(14):1498-9; author reply 1499-500. PubMed ID: 17024740
[No Abstract] [Full Text] [Related]
4. N-acetylcysteine and contrast-induced nephropathy.
Ritz E
N Engl J Med; 2006 Oct; 355(14):1499; author reply 1499-500. PubMed ID: 17024738
[No Abstract] [Full Text] [Related]
5. Contrast-induced acute kidney injury. Underappreciated or a new marker of cardiovascular mortality?
Mehran R; Brar S; Dangas G
J Am Coll Cardiol; 2010 May; 55(20):2210-1. PubMed ID: 20466201
[No Abstract] [Full Text] [Related]
6. N-acetylcysteine and contrast-induced nephropathy.
Wolak A; Cafri C; Zahger D
N Engl J Med; 2006 Oct; 355(14):1498; author reply 1499-500. PubMed ID: 17024739
[No Abstract] [Full Text] [Related]
7. Contrast loaded with N-acetylcysteine for coronary imaging during percutaneous coronary intervention: a new concept for renal and myocardial protection during percutaneous coronary intervention.
Fischell TA
JACC Cardiovasc Interv; 2009 Mar; 2(3):222-3. PubMed ID: 19463429
[No Abstract] [Full Text] [Related]
8. Effect of N-acetylcysteine on cystatin C-based renal function after elective coronary angiography (ENABLE Study): a prospective, randomized trial.
Kim BJ; Sung KC; Kim BS; Kang JH; Lee KB; Kim H; Lee MH
Int J Cardiol; 2010 Feb; 138(3):239-45. PubMed ID: 18793808
[TBL] [Abstract][Full Text] [Related]
9. The value of hydration and acetylcysteine in the prevention of contrast-induced nephropathy: a potentially catastrophic complication of the percutaneous coronary interventions.
Iyisoy A; Celik T; Yuksel UC; Bugan B; Isik E
Int J Cardiol; 2009 May; 134(3):431-3; author reply 434. PubMed ID: 18501445
[TBL] [Abstract][Full Text] [Related]
10. Abbreviated dosing of N-acetylcysteine prevents contrast-induced nephropathy after elective and urgent coronary angiography and intervention.
Ochoa A; Pellizzon G; Addala S; Grines C; Isayenko Y; Boura J; Rempinski D; O'Neill W; Kahn J
J Interv Cardiol; 2004 Jun; 17(3):159-65. PubMed ID: 15209578
[TBL] [Abstract][Full Text] [Related]
11. Does N-acetylcysteine reduce the incidence of contrast-induced nephropathy and clinical events in patients undergoing primary angioplasty for acute myocardial infarction?
Tanaka A; Suzuki Y; Suzuki N; Hirai T; Yasuda N; Miki K; Fujita M; Tanaka T
Intern Med; 2011; 50(7):673-7. PubMed ID: 21467697
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of N-acetylcysteine and hydration versus placebo and hydration in decreasing contrast-induced renal dysfunction in patients undergoing coronary angiography with or without concomitant percutaneous coronary intervention.
Seyon RA; Jensen LA; Ferguson IA; Williams RG
Heart Lung; 2007; 36(3):195-204. PubMed ID: 17509426
[TBL] [Abstract][Full Text] [Related]
13. Sodium bicarbonate, N-acetylcysteine, and saline for the prevention of contrast-induced nephropathy.
Bouzas-Mosquera A; Recio-Mayoral A
Am Heart J; 2008 Apr; 155(4):e31. PubMed ID: 18371455
[No Abstract] [Full Text] [Related]
14. Contrast-induced nephropathy remains a serious complication of PCI.
Mehran R
J Interv Cardiol; 2007 Jun; 20(3):236-40. PubMed ID: 17524117
[No Abstract] [Full Text] [Related]
15. Prevention of contrast-induced renal dysfunction by N-acetylcysteine. Truth or myth?
Billinger M; Hess OM; Meier B
Eur Heart J; 2004 Feb; 25(3):188-9. PubMed ID: 14972417
[No Abstract] [Full Text] [Related]
16. Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study.
Ferrario F; Barone MT; Landoni G; Genderini A; Heidemperger M; Trezzi M; Piccaluga E; Danna P; Scorza D
Nephrol Dial Transplant; 2009 Oct; 24(10):3103-7. PubMed ID: 19549691
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of N-acetylcysteine and aminophylline in preventing contrast-induced nephropathy.
Kinbara T; Hayano T; Ohtani N; Furutani Y; Moritani K; Matsuzaki M
J Cardiol; 2010 Mar; 55(2):174-9. PubMed ID: 20206069
[TBL] [Abstract][Full Text] [Related]
18. Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature.
Goldenberg I; Shechter M; Matetzky S; Jonas M; Adam M; Pres H; Elian D; Agranat O; Schwammenthal E; Guetta V
Eur Heart J; 2004 Feb; 25(3):212-8. PubMed ID: 14972421
[TBL] [Abstract][Full Text] [Related]
19. Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy.
Allaqaband S; Tumuluri R; Malik AM; Gupta A; Volkert P; Shalev Y; Bajwa TK
Catheter Cardiovasc Interv; 2002 Nov; 57(3):279-83. PubMed ID: 12410497
[TBL] [Abstract][Full Text] [Related]
20. N-acetylcysteine for prevention of radiocontrast induced nephrotoxicity: the importance of dose and route of administration.
Shalansky SJ; Pate GE; Levin A; Webb JG
Heart; 2005 Aug; 91(8):997-9. PubMed ID: 16020580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
